June 24, 2011 – Endo Pharmaceuticals issued a voluntary nationwide consumer level recall of Endocet® (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV. One bottle from each lot of Endocet® (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg, Lot # 402415NV and # 402426NV, NDC 60951-712-70, 100 count bottles, [...]

June 24, 2011 – Qualitest Pharmaceuticals issued a voluntary nationwide retail level recall of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, and Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg/500mg. This recall was initiated because an individual bottle of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, 500 counts was found incorrectly labeled with a Hydrocodone Bitartrate [...]

April 19, 2011 – Johnson & Johnson on Thursday announced a recall of 57,000 bottles of the prescription anti-seizure medication Topamax following consumer complaints of an “uncharacteristic odor.” Johnson & Johnson says the recall represents two lots of the Topamax 100 mg tablets made by its Ortho-McNeil Neurologics division. The affected drugs were shipped and [...]

March 17, 2011 – Morphine/naltrexone extended-release capsules did not meet stability requirement; will be unavailable for “many months.” King Pharmaceuticals Inc. announced that a voluntary recall of all dosage forms of Embeda (morphine/naltrexone) extended-release capsules from U.S. wholesalers and retailers. King reported that Embeda did not meet a pre-specified stability requirement during routine testing. Based [...]

February 12, 2011 – The U.S. Food and Drug Administration (FDA) has approved Viibryd (vilazodone HCl) oral tablets to treat Major Depressive Disorder (MDD) in adults.  Viibryd is included in a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs).  Viibryd is made by PGX Health, a New Haven, CT company, and is expected [...]